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The concurrence of amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) is extremely rare. We reported the case of a
33-year-old woman with a past history of paresthesias at the right hand, who developed progressive quadriparesis with muscular
atrophy of limbs and, ﬁnally, bulbar signs and dyspnea. Clinical and neurophysiologic investigations revealed upper and lower
motor neuron signs in the bulbar region and extremities, suggesting the diagnosis of ALS. Moreover, magnetic resonance imaging
(MRI) and cerebrospinal ﬂuid (CSF) analysis demonstrated 3 periventricular and juxtacortical lesions, hyperintense in T2 and
FLAIR sequences, and 3 liquoral immunoglobulin G (IgG) oligoclonal bands, consistent with diagnosis of primary progressive
MS (PPMS). This unusual overlap of ALS and MS leads to the discussion of a hypothetical common pathological process of
immunological dysfunction in these two disorders, although the role of immune response in ALS remains ambivalent and unclear.
1.Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative
disorder, characterized by progressive weakness of limb,
bulbar, and respiratory muscles, with an annual incidence in
Europe of 2.16/100.000 person years [1]. Multiple sclerosis
(MS), an inﬂammatory disease of the central nervous system
(CNS) with dissemination of demyelinating lesions in time
and space, mainly aﬀects young adults and has a variable
incidence by racial heritage and geographic region (0.8 to
12/100.000 person years) [2]. Thus, the concurrence of these
two neurological disorders is extremely infrequent [3–6],
althoughrecentexplanatorystudieshavesuggestedapossible
familial aggregation between MS and ALS [7, 8].
We report the clinical and radiological ﬁndings of a
young woman with the unusual combination of ALS and
MS, also reviewing the limited literature on the coexistence
of these two disorders in the same patient.
2.CaseReport
Our patient was a 33-year-old woman, who noted persistent
paresthesias and progressive weakness at the right hand,
signiﬁcantly decreased after three months without requiring
therapy. One year later, she experienced worsening of
weakness and appearance of atrophy at the right arm, which
gradually extended at the left arm and lower limbs. After
eight months, dysphagia, dysarthria, and dyspnea occurred.
Her familial and past medical history was not indicative
ofpathologicconditions.ThepatientcomesfromLacedonia,
in the South of Italy near Avellino, and her family came
from the nearby town of Belvedere Marittima for several
generations.
Neurological examination revealed dysphagia and dysar-
thria, with mild tongue atrophy, spastic quadriparesis, brisk
upper and lower extremity reﬂexes, pyramidal signs, and
widespread atrophies of the limbs muscles. The sensory2 Case Reports in Medicine
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Figure 1: Axial (a) and coronal (b) FLAIR MR images showing
typical hyperintensities of pyramidal tracts (solid line), from motor
cortices to bulbar pyramids. In this context, periventricular and
juxtacortical lesions, hyperintense in T2 and FLAIR (dashed line),
were observed.
exam was normal. The laboratory exams were all normal.
Speciﬁcally, we performed serum dosage of anti-nucleus,
anti-DNA and anti-cardiolipin antibodies and both serum
and cerebrospinal ﬂuid (CSF) dosage of anti-gangliosides
GM1, anti-viral (hepatitis virus B and C, Herpesviridae,
Morbillivirus, Rubivirus, Enterovirus, adenovirus, paramyx-
ovirus, respiratory syncytial virus, and Retroviridae-human
T-lymphotropic virus-1 or HTLV-1 and human immunode-
ﬁciency virus or HIV) and anti-Borrelia antibodies.
Electromyography (EMG) showed pathological spon-
taneous activity at rest (ﬁbrillations and fasciculations)
and chronic, neurogenic motor unit changes in three sites
(bulbar, upper and lower limbs), whilst motor and sensory
nerve conductions were normal and conduction blocks were
not detected.
Brain MRI showed bilaterally T2 and ﬂuid attenuate
inversion recovery (FLAIR) hyperintensities of pyramidal
tractsandprecentralcortexes,togetherwith3periventricular
or juxtacortical white matter lesions, hyperintense in T2 and
FLAIR sequences (Figure 1), and gadolinium enhancement
of the lesion in the right corona radiata. No abnormal areas
were evident in the spinal cord. These MRI scans were
performed at 1.5 Tesla, about two years after the ﬁrst symp-
toms onset (i.e., when the patient came to our observation
for the ﬁrst time). To exclude possible coexistent tumor or
inﬂammatory conditions, the patient underwent a whole
body 18-ﬂuorodeoxyglucose-positron emission tomography
(FDG-PET) study six months later, which did not identify
areas of abnormal cellular metabolism, and also brain and
spinal MRI scans, which did not show novel pathological
areas. Afterwards, no other MRI exam has been performed
because of the progressive impairment of the respiratory
function of the patient.
The cerebrospinal ﬂuid (CSF) analysis detected an
increased immunoglobulin G (IgG) or Link index (0.8) and
3 IgG oligoclonal bands (OCBs) by isoelectric focusing,
without evidence of barrier injury. The CSF was negative for
viral and Lyme antibodies.
We screened genetic susceptibility to motor neuron
disorders by testing some genes linked to similar phenotypes
of ALS in the Italian population: we did not found any
mutation of superoxide dismutase 1 (SOD1), transactive
response-DNA binding protein (TARDBP), fusion in malig-
nant liposarcoma/translocated in liposarcoma (FUS/TLS)
and C9ORF72 genes.
We assumed that in this remarkable case the diagnostic
criteria for both ALS [9] and primary progressive MS
(PPMS) [10]w e r ef u l ﬁ l l e d .
The patient was treated with riluzole (50mg × two/die)
and physiotherapy. She is receiving artiﬁcial respiratory
support (noninvasive ventilation) from about six months
after the diagnosis of ALS because of the worsening of
respiratory function (forced vital capacity or FVC < 50%).
3. Discussion
We report clinical and instrumental ﬁndings about an
intriguing case of overlap between ALS and MS. Speciﬁcally,
besides the diagnostic criteria for ALS [9], in this case
the 2010 McDonald criteria for diagnosis of MS with an
insidious neurological progression (PPMS) were also met
[10]. In fact, our patient presented at least one year of insid-
ious neurological progression, in addition to (i) evidence
for dissemination of brain lesions in space (DIS), based
on ≥1 T2 lesions in the MS-characteristic (periventricular,
juxtacortical, or infratentorial) regions, and (ii) positive
CSF analysis (isoelectric focusing evidence of OCBs and/or
elevated IgG index).
In particular, in our case the clinical course of the
two concomitant neurological disorders evokes the previous
reports of Dynes et al. [3]a n dL ie ta l .[ 4] who observed the
neuropathological coexistence and the simultaneous clinical
progression of both ALS and MS. Interestingly, they have
been identiﬁed as key pathological features degeneration of
pyramidaltractsandanterior hornscellsinboth cervicaland
lumbar cord in addition to multiple demyelinating plaques
in prototypic locations (i.e., cortex, periventricular region,
corpus callosum, brainstem, and spinal cord). Undoubtedly,
a relevant limitation of our report is the lack of an autoptic
conﬁrmation of ALS and MS coexistence, although clinical
and instrumental ﬁndings are suggestive of this overlap of
neurological diseases in our patient.
About the detection of CSF OCBs in our case, it is
remarkable that an intrathecal synthesis of IgG may be
observed also in patients with ALS alone, although in a small
subset (approximately 0.5–3.5%) [11, 12]. Interestingly, in a
recent study by Ticozzi et al. [12], CSF was collected from
259 patients with ALS, screened also for mutations of SOD1,
FUS, TARDBP, angiogenin (ANG), optineurin (OPTN), and
C9ORF72 genes. It was found that, among patients with
OCBs,twopatientshadtheTARDBPp.A382Tmutation(one
of which in homozygous state), and one the ANG p.P-4SCase Reports in Medicine 3
variant. These results prompted to hypothesize that muta-
tions in both TARDBP and ANG genes may have induced
damage of the blood-brain barrier (BBB), promoting local
immune responses and neuroinﬂammation.
Other than the above-mentioned pathologic descrip-
tions, among the rare clinical reports of patients with both
ALS and MS, Hewitt et al. [5] observed the coexistence of
MS and familial ALS (FALS) in a patient with mutation of
FUS/TLS gene (p.Gly174del), and, more recently, Ismail et
al. [6] identiﬁed the C9ORF72 expansion in 80% of patients
withMS-ALSamongalargepopulationofALSpatientsfrom
the North of England. Remarkably, further recent evidences
give clues about the genetic similarities that the two diseases
share. In fact, it has been revealed that ﬁrst degree relatives
of MS patients are signiﬁcantly more prone to ALS and vice
versa [7, 8].
Interestingly, in patients with MS lower motor neuron
dysfunctionhasbeenoccasionallyreported,particularlywith
impairment of motor functions of the hands and sometimes
associated with MRI detection of cervical plaques [13, 14].
In our report, no evidence of demyelinating plaques in the
spinal cord was observed. However, our longitudinal MRI
examination was limited in time because of the onset of
respiratory failure which made diﬃcult to execute follow-up
MRI scans.
Although we do not aim to suggest any causative re-
lationship between ALS and MS, we hypothesize that this
association might probably be induced by some common
pathological mechanisms of interplay between inﬂammation
anddegenerationinbothdisorders.Infact,severalneurolog-
ical diseases, including ALS and MS, are currently associated
with chronic neuroinﬂammation [4, 6, 15]. Despite the
prominent role of the autoimmunity in the pathogenesis of
MS, the manifold characteristics of immune response in ALS
arebeginningtobeappreciated,althoughtheyremainlargely
unclear [6, 15].
4. Conclusions
We assume that our unusual report, in addition to the
limited literature on the concurrence of ALS and MS, might
be useful to stimulate further analyses on the unknown
physiopathological aspects of these two disorders, even to
shed light on the role of the immune response in the
pathogenesis of ALS.
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